Canada markets closed

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.4400+0.0100 (+0.70%)
At close: 04:00PM EDT
1.4200 -0.02 (-1.39%)
After hours: 07:45PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.4300
Bid1.3800 x 100
Ask1.4900 x 100
Day's Range1.2699 - 1.4900
52 Week Range1.2699 - 7.5900
Avg. Volume117,309
Market Cap26.474M
Beta (5Y Monthly)1.80
PE Ratio (TTM)N/A
EPS (TTM)-0.7900
Earnings DateJun 10, 2024 - Jun 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • GlobeNewswire

    BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

    83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression free survival (PFS) of 4.1 months in ADC resistant patients - double the PFS of patients in similar studies1,2,3Clinical benefit rate of 55% in evaluable patients includes HR+, HER2+ and TNBC disease - much higher than comparable studies1,2,3 PHILADELPHIA and VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics C

  • Simply Wall St.

    This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

    Looking at BriaCell Therapeutics Corp.'s ( TSE:BCT ) insider transactions over the last year, we can see that insiders...

  • GlobeNewswire

    BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

    PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced it has closed its previously announced registered direct offering with healthcare-focused institutional investors and a certain existing investor and a director of the Company for the purchase and sale of 2,402,9